10-KPeriod: FY2005

CVS HEALTH Corp Annual Report, Year Ended Jan 1, 2005

Filed March 16, 2005For Securities:CVS

Summary

CVS Corporation's 2004 10-K filing highlights a year of significant growth, primarily driven by the substantial acquisition of Eckerd's retail drugstores and pharmacy benefit management (PBM) businesses. This acquisition significantly expanded CVS's retail footprint and market share, positioning it as the largest drugstore retailer in the U.S. The company's strategy emphasizes convenience, service, and technological innovation in its retail pharmacy operations, with pharmacy sales continuing to outpace front-store sales, a trend expected to persist due to demographic shifts and healthcare trends. The Pharmacy Benefit Management (PBM) division, operating as PharmaCare Management Services, also saw expansion, solidifying its position as a major PBM. CVS continues to invest heavily in its store base and information systems to enhance efficiency and customer experience. The company also noted a robust increase in net sales and is committed to returning value to shareholders through consistent dividend payments and a planned increase for 2005.

Key Highlights

  • 1Acquisition of Eckerd's assets and liabilities, including 1,268 retail drugstores and its PBM business, significantly expanding CVS's market presence.
  • 2CVS now operates 5,375 retail and specialty pharmacy stores, holding the number one or two market share in 73% of its operating markets.
  • 3Pharmacy sales accounted for 70% of net sales in 2004, demonstrating a continued shift towards prescription-related revenue.
  • 4The ExtraCare® loyalty program boasts over 50 million members, serving as a key tool for customer retention and targeted marketing.
  • 5Significant investment in information systems, including the EPIC and AIM systems, to improve operational efficiency and customer service.
  • 6Net sales reached $30.6 billion for the fiscal year ended January 1, 2005, an increase driven by organic growth and acquisitions.
  • 7The company declared a 9% increase in its common stock dividend for the first quarter of 2005, signaling confidence in financial performance.

Frequently Asked Questions

The most significant event was the acquisition of certain assets and liabilities from J.C. Penney Company, Inc. and its subsidiaries, including Eckerd Corporation. This acquisition brought 1,268 Eckerd retail drugstores and Eckerd's mail order and PBM businesses into the CVS portfolio, substantially increasing its scale and market share.

The Retail Pharmacy segment is the dominant business, representing approximately 94% of consolidated net sales in 2004. The Pharmacy Benefit Management (PBM) segment contributed the remaining 6% of net sales. Pharmacy sales themselves constituted 70% of total net sales in 2004.

CVS has implemented its highly successful ExtraCare® card program, which had over 50 million members as of January 1, 2005. This program allows CVS to reward its best customers with automatic sale prices, customized coupons, and ExtraBucks™ rewards, fostering loyalty and enabling personalized marketing efforts.

The filing mentions ongoing securities litigation (In re CVS Corporation Securities Litigation), an ERISA class action lawsuit (Fescina v. CVS Corp.), and a shareholder derivative suit (Krantz v. Ryan). Additionally, CVS is cooperating with investigations by the Rhode Island Attorney General's office, the Rhode Island Ethics Commission, and the U.S. Attorney's Office for the District of Rhode Island. There are also ongoing investigations by the Department of Justice and several state attorneys general concerning prescription drug dispensing practices. While CVS believes these actions are without merit and intends to defend them vigorously, significant legal matters could potentially impact the company.